How two hospitals and a pharma company are coming together to improve clinical research

How partnering across organizations is bringing decentralized clinical trials to patients and allowing them to participate on their own terms.

Clinical trial activity in Ontario, and worldwide, has been impacted by the COVID-19 pandemic. Since the onset of the pandemic, clinical trial sites and sponsors have been tasked with the challenge of conducting clinical trials safely in our current reality.

Ontario’s clinical trials community has shown incredible resilience and innovation by implementing digital, virtual, and decentralized clinical trial processes in order to keep clinical trials moving forward in a safe and socially distant manner. These decentralized approaches, once seen as an immediate risk mitigation tactic during the pandemic, are now recognized as a highly effective and participant-centric option for conducting clinical trials.

Read the full story on 

Related Stories

Exploring Innovative Remote Monitoring Solutions at Lawson Health Research Institute – Clinical Trials Ontario| Clinical Trials Ontario (

COVID-19: Ontario’s clinical trials community rising to the challenge – Clinical Trials Ontario| Clinical Trials Ontario (

Rising to the Challenge: Resuming Clinical Research at the University Health Network – Clinical Trials Ontario| Clinical Trials Ontario (

How Private Research Networks are responding to the COVID-19 Pandemic – Clinical Trials Ontario| Clinical Trials Ontario (

More CTO Stories